Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

InspireMD

AMEX NSPR
$2.01 0.0000 0.0000%
Today share price
Israel
Sector: Healthcare Industry: Health Care Equipment & Supplies
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 20 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

48.78M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
39.70M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.83
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
24.27M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-28.47 %

Upcoming events InspireMD

All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart InspireMD

Stock analysis InspireMD

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-2.46 -5.57
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
1.23 3.34
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-1.90 -6.57
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.43 0.43
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-50.10 -50.10

Price change InspireMD per year

3.60$ 22.20$
Min Max

Summary analysis InspireMD

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure InspireMD

Revenue and net income InspireMD

All parameters

Stock news InspireMD

All news
15 May 2023 в 15:50

InspireMD Prices $113.6M Private Placement With Institutional Healthcare Investors

15 May 2023 в 15:50

InspireMD Prices $113.6M Private Placement With Institutional Healthcare Investors

1 March 2022 в 14:51

InspireMD stock price target cut to $9.00 from $16.50 at Alliance Global

13 October 2021 в 16:10

InspireMD Shares Rise 20% Premarket After Positive Opinion in France

13 October 2021 в 16:10

InspireMD Shares Rise 20% Premarket After Positive Opinion in France

22 September 2019 в 01:02

ЛИДЕРЫ УОЛЛ-СТРИТ-InspireMD, Roku, Netflix, McDermott International, California Resources

About company InspireMD

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
Address:
4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832
Company name: InspireMD
Issuer ticker: NSPR
ISIN: US45779A8466
Country: Israel
Exchange: AMEX
Currency: $
IPO date: 2011-04-12
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.inspiremd.com

On which stock exchange are InspireMD (NSPR) stocks traded?

InspireMD (NSPR) stocks are traded on AMEX.

What is the ticker of InspireMD stocks (NSPR)?

The stock ticker of InspireMD’s stocks or in other words, the code is NSPR. The stocks are currently listed on the AMEX exchange.

In which sector and industry does InspireMD (NSPR) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, InspireMD (NSPR) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are InspireMD (NSPR) stocks traded?

InspireMD (NSPR) stocks are traded on the AMEX exchange in dollars.

What is the price of InspireMD (NSPR) stocks today?

The current price of InspireMD stocks on 04.05.2024 is 2.01 dollars. per share.

What is the dynamics of InspireMD (NSPR) stocks from the beginning of the year?

InspireMD (NSPR) quotes have increased by -25.83% from the beginning of the year up to 2.01 dollars. per 1 stocks.

How much did InspireMD (NSPR) stocks increase in мае 2024?

This month InspireMD (NSPR) quotes have increased by 2.89% to 2.01 dollars. per share.

How much are InspireMD (NSPR) stocks worth?

Today, on October, 04.05.2024 InspireMD’s (NSPR) stocks cost 2.01 dollars..

What is the market capitalization of InspireMD (NSPR)?

Capitalization is the market value of InspireMD (NSPR) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 04.05.2024, the market capitalization of InspireMD (NSPR) is estimated at about 48779044 dollars.